Delivery Order SPE2DB20D2104-SPE2DB25FMPPX

Award Date 4/29/25
Potential Completion Date 4/30/25
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $24,566.16 contract is for the procurement of ROTARIX vaccine oral syringes, 1.5 mL, with a period of performance through December 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the ROTARIX vaccine in oral syringes. The contract has a ceiling value of $1,514.90 and a period of performance through December 30, 2024. It is a firm-fixed price contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support...
This firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation, provides the Rotarix vaccine in oral syringes to DLA Troop Support Medical. The $3,661.95 contract has a performance period through March 2024 and is not associated with any set-aside designations. In addition to this delivery order, AmerisourceBergen Drug Corp holds an indefinite delivery contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,002.42 contract is for the supply of ROTARIX vaccine oral syringes, 1.5mL in size. The contract has an ultimate completion date of August 28, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,654.02 firm fixed-price contract is for the delivery of the ROTARIX vaccine oral syringes (1.5 mL) and has an ultimate completion date of October 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a $10,251.67 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ROTARIX vaccine oral syringes (1.5mL) and has an ultimate completion date of January 13, 2025. This delivery order is placed under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the Rotarix vaccine oral syringes. The $1,450.30 firm fixed-price contract has a period of performance through March 2024. AmerisourceBergen, a major pharmaceutical distributor, is delivering the vaccine products under an Indefinite Delivery Contract (IDC) valued at $999,999,999 with DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $21,930.60 firm fixed price contract is for the supply of the ROTARIX vaccine oral syringe 1.5 ml. The contract has an ultimate completion date of March 21, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 for a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,926,398 units of the ROTARIX vaccine oral syringe, 1.5 ml in size. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $7,606.35 and a performance period through April 16, 2025. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of ROTARIX vaccine oral syringes. The contract has a ceiling value of $6,265.69 and runs through April 8, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMPPX
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Rotarix vaccine oral syringes. The contract has a ceiling value of $3,458.03 and a period of performance through April 30, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This delivery order is not set aside and represents a small-volume purchase under the broader IDC, demonstrating AmerisourceBergen's capacity to fulfill varied federal medical supply requirements, including for military and veteran healthcare systems.

Generated 7/29/25, 9:45 AM